Showing results (621-630 of 2,814) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|March 6, 2025
Continuous Glucose Monitoring in Type 1 Diabetes, Type 2 Diabetes, and Diabetes During Pregnancy: A Systematic Review with Meta-Analysis of Randomized Controlled TrialsEvangelos C Rizos, Georgios Markozannes, Nikolaos Charitakis, et al.Diabetes Technology & Therapeutics|January 8, 2025
The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular ComplicationsBoris P Kovatchev, Benjamin Lobo, Chiara Fabris, et al.Diabetes Technology & Therapeutics|January 6, 2025
A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking InsulinThomas W Martens, Holly J Willis, Richard M Bergenstal, et al.Diabetes Technology & Therapeutics|March 11, 2025
Automated Insulin Delivery in Elderly with Type 1 Diabetes: A Prespecified Analysis of the Extension PhaseYogish C Kudva, Robert J Henderson, Lauren G Kanapka, et al.Diabetes Technology & Therapeutics|September 3, 2024
Clinical Utility of Serum C-Peptide Concentration for Hospitalized Patients with HyperglycemiaDamla N Costa, Yogish C Kudva, Michael D Jensen, et al.Diabetes Technology & Therapeutics|August 23, 2024
Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin TherapyKasia J Lipska, Carol Oladele, Kelson Zawack, et al.Diabetes Technology & Therapeutics|July 25, 2024
Beyond Glucose Monitoring: Multianalyte Sensor Use in DiabetesKathy Zhou, Steven James, Michele Gaca, et al.Diabetes Technology & Therapeutics|July 25, 2024
Frequency of Rebound Hyperglycemia in Adults with Type 1 Diabetes Treated with Different Insulin Delivery ModalitiesKatrine Grønbæk Tidemand, Christian Laugesen, Ajenthen Gayathri Ranjan, et al.Diabetes Technology & Therapeutics|August 8, 2024
From Stability to Variability: Classification of Healthy Individuals, Prediabetes, and Type 2 Diabetes Using Glycemic Variability Indices from Continuous Glucose Monitoring DataSimon Lebech Cichosz, Thomas Kronborg, Esben Laugesen, et al.Diabetes Technology & Therapeutics|July 30, 2024
Novel Glucose Metric "Latest Spike Time" Correlated with Weight Loss at Six Months in People with Obesity Using the Signos SystemWilliam Dixon, Stephanie Kim, Dmitri Levonian, et al.Pageof 282